Trinity Biotech
TRIB
92 hedge funds and large institutions have $323M invested in Trinity Biotech in 2015 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 31 increasing their positions, 27 reducing their positions, and 5 closing their positions.
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
15% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 27
6% more capital invested
Capital invested by funds: $303M → $323M (+$19.3M)
5% more funds holding
Funds holding: 88 → 92 (+4)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
38% less call options, than puts
Call options by funds: $287K | Put options by funds: $466K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$9.09M |
| 2 |
SM
Senvest Management
New York
|
+$7.95M |
| 3 |
Boston Partners
Boston,
Massachusetts
|
+$5.16M |
| 4 |
DM
Deerfield Management
New York
|
+$4.55M |
| 5 |
RFC
Russell Frank Company
Seattle,
Washington
|
+$4.03M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LSC
Lyon Street Capital
Sausalito,
California
|
-$6.87M |
| 2 |
Millennium Management
New York
|
-$5.51M |
| 3 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$1.24M |
| 4 |
KCM
Keane Capital Management
Charlotte,
North Carolina
|
-$938K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$892K |
TRIB Hedge Fund Activity: Q2 2015 in Review
92 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Trinity Biotech (TRIB) for Q2 2015, worth a combined $323M — up 6.4% from $303M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new TRIB positions and 5 closed out — a net gain of 4 holders — while 31 added to existing stakes and 27 trimmed.
The largest buyer was Janus Henderson Investors US, opening a new position worth an estimated $9.09M. The largest seller was Lyon Street Capital, cutting an estimated $6.87M.
- 92 institutional investors held Trinity Biotech (TRIB) as of Q2 2015, up from 88 in Q1 2015.
- Funds reported $323M of Trinity Biotech stock for Q2 2015, up 6.4% quarter-over-quarter.
- 9 funds opened new Trinity Biotech positions in Q2 2015 and 5 closed out, a net change of +4 holders.
- The largest Trinity Biotech buyer in Q2 2015 was Janus Henderson Investors US, an estimated $9.09M added.
- The largest Trinity Biotech seller in Q2 2015 was Lyon Street Capital, an estimated $6.87M sold.
Based on aggregated 13F filings for Q2 2015.